FrenchieGirl
Senior Moderator
Risk of transmission of Ebola virus via
donated blood and other substances
of human origin in the EU
Travellers or residents returning from EVD-affected areas
Deferment - 2 months
Individuals monitored after exposure to Ebola virus
Deferment - 2 months from the beginning of the monitoring period.
Individuals infected with Ebola virus
Excluded - alive or dead
Individuals recovered from EVD
Deferment - 12 months following recovery from a viral haemorrhagic fever. In addition, living or deceased donors of SoHO should have
tested negative for Ebola virus by NAT
EXCEPTIONS
Donations of convalescent blood for post-exposure treatment
The above recommendations do not apply to donations of convalescent whole blood (CWB) and plasma (CP) from EVD survivors for the preparation of convalescent plasma for post-exposure treatment. WHO has recently issued guidance on such donations for empirical treatments [12]. WHO currently recommends that only those EVD patients who have been discharged in accordance with WHO criteria (i.e. clinically asymptomatic one month after discharge and tested negative twice for Zaire ebolavirus by NAT) should be eligible for such donations
donated blood and other substances
of human origin in the EU
Travellers or residents returning from EVD-affected areas
Deferment - 2 months
Individuals monitored after exposure to Ebola virus
Deferment - 2 months from the beginning of the monitoring period.
Individuals infected with Ebola virus
Excluded - alive or dead
Individuals recovered from EVD
Deferment - 12 months following recovery from a viral haemorrhagic fever. In addition, living or deceased donors of SoHO should have
tested negative for Ebola virus by NAT
EXCEPTIONS
Donations of convalescent blood for post-exposure treatment
The above recommendations do not apply to donations of convalescent whole blood (CWB) and plasma (CP) from EVD survivors for the preparation of convalescent plasma for post-exposure treatment. WHO has recently issued guidance on such donations for empirical treatments [12]. WHO currently recommends that only those EVD patients who have been discharged in accordance with WHO criteria (i.e. clinically asymptomatic one month after discharge and tested negative twice for Zaire ebolavirus by NAT) should be eligible for such donations